Mycobacterium abscessus Chest Wall and Pulmonary Infection in a Cystic Fibrosis Lung Transplant Recipient

2006 ◽  
Vol 25 (8) ◽  
pp. 985-988 ◽  
Author(s):  
Jennifer L. Taylor ◽  
Scott M. Palmer
Keyword(s):  
Cystic Fibrosis ◽  
Transplant Recipient ◽  
Chest Wall ◽  
Lung Transplant ◽  
Pulmonary Infection ◽  
Mycobacterium Abscessus ◽  
Cystic Fibrosis Lung ◽  
Lung Transplant Recipient

scholarly journals Burkholderia Gladioli– A Predictor of Poor Outcome in Cystic Fibrosis Patients Who Receive Lung Transplants? A Case of Locally Invasive Rhinosinusitis and Persistent Bacteremia in a 36-Year-Old Lung Transplant Recipient with Cystic Fibrosis

2011 ◽  
Vol 18 (4) ◽  
pp. e64-e65 ◽  
Author(s):  
Bradley S Quon ◽  
James D Reid ◽  
Patrick Wong ◽  
Pearce G Wilcox ◽  
Amin Javer ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Transplant Recipient ◽  
Lung Transplant ◽  
Lung Transplant Recipient ◽  
Transplant Outcomes ◽  
Poor Outcome ◽  
Burkholderia Gladioli ◽  
Persistent Bacteremia ◽  
Lung Transplants

There have been very few reports describing postlung transplant outcomes in patients’ infected/colonized withBurkholderia gladiolipretransplant. A case involving a lung transplant recipient with cystic fibrosis who ultimately died as a result of severe rhinosinusitis due toB gladioliinfection in the context of postlung transplant immunosuppression is reported.

scholarly journals Effective Prolonged Therapy with Voriconazole in a Lung Transplant Recipient with Spondylodiscitis Induced byScedosporium apiospermum

2011 ◽  
Vol 2011 ◽  
pp. 1-4 ◽  
Author(s):  
B. Luijk ◽  
M. B. Ekkelenkamp ◽  
P. A. De Jong ◽  
J. M. Kwakkel-van Erp ◽  
J. C. Grutters ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Transplant Recipient ◽  
Lung Transplantation ◽  
Lung Transplant ◽  
Surgical Intervention ◽  
Invasive Disease ◽  
Lung Transplant Recipient ◽  
Scedosporium Apiospermum ◽  
Fungal Treatment ◽  
Anti Fungal

Scedosporium/Pseudallescheriaspecies are frequently seen in cystic fibrosis patients. However, disseminated forms after lung transplantation in these patients are rarely seen, but often with poor outcome. In this case report we describe a lung transplant recipient with cystic fibrosis who developed a spondylodiscitis that was caused byScedosporium apiospermum. The patient was treated with anti-fungal treatment by voriconazole for over three years with a clinical good response and without the need for surgical intervention. To our opinion this is the first anti-fungal treated case of invasive disease caused byScedosporium/Pseudallescheriain a cystic fibrosis (CF) patient who underwent lung transplantation that survived.

Mycobacterium abscessus empyema in a lung transplant recipient

2002 ◽  
Vol 21 (3) ◽  
pp. 391-394 ◽  
Author(s):  
Rick M Fairhurst ◽  
Bernard M Kubak ◽  
Robert B Shpiner ◽  
Michael S Levine ◽  
David A Pegues ◽  
...  
Keyword(s):  
Transplant Recipient ◽  
Lung Transplant ◽  
Mycobacterium Abscessus ◽  
Lung Transplant Recipient

MYCOBACTERIUM ABSCESSUS CAUSING DISSEMINATED SKIN INFECTION IN A LUNG TRANSPLANT RECIPIENT

CHEST Journal ◽  
2019 ◽  
Vol 156 (4) ◽  
pp. A1387-A1388 ◽  
Author(s):  
Sreeja Biswas Roy ◽  
Hesham Abdelrazek ◽  
Thomas Luzny ◽  
Rajat Walia ◽  
Tanmay Panchabhai
Keyword(s):  
Transplant Recipient ◽  
Lung Transplant ◽  
Skin Infection ◽  
Mycobacterium Abscessus ◽  
Lung Transplant Recipient

Lower third chest wall reconstruction in a bilateral sequential lung transplant recipient

2021 ◽  
Vol 14 (1) ◽  
pp. e238998
Author(s):  
Pennylouise Hever ◽  
Prateush Singh ◽  
Dariush Nikkhah ◽  
Vladimir Anikin
Keyword(s):  
Transplant Recipient ◽  
Chest Wall ◽  
Lung Transplant ◽  
Chest Wall Reconstruction ◽  
Lung Transplant Recipient ◽  
Deep Sternal Wound Infection ◽  
Unique Challenge ◽  
Surgical History ◽  
Advancement Flaps ◽  
Bilateral Lung

Reconstruction of the sternum following deep sternal wound infection (DSWI) can be challenging, and despite advances in reconstructive surgery, DSWI remains a significant cause of morbidity and mortality in cardiothoracic patients. Transplantation patients present an additional, unique challenge for the reconstructive surgeon. These patients are often on immunosuppressant therapy, with multiple comorbidities, and cannot tolerate prolonged operations for reconstruction. They often have a prior extensive surgical history, which may limit donor options; and their wounds are often in the lower third of the sternum, which is a challenging location to reconstruct with locoregional tissues.We report a case of successful lower third chest wall reconstruction in a bilateral lung transplant recipient with a combination of bilateral pectoralis advancement flaps and omentoplasty.

scholarly journals Ceftolozane-tazobactam pharmacokinetics during extracorporeal membrane oxygenation in a lung transplant recipient

2018 ◽  
Author(s):  
Fabio Arena ◽  
Luca Marchetti ◽  
Lucia Henrici De Angelis ◽  
Enivarco Maglioni ◽  
Martina Contorni ◽  
...  
Keyword(s):  
Pseudomonas Aeruginosa ◽  
Transplant Recipient ◽  
Extracorporeal Membrane Oxygenation ◽  
Lung Transplant ◽  
Drug Exposure ◽  
Pulmonary Infection ◽  
Lung Transplant Recipient ◽  
Membrane Oxygenation ◽  
Optimal Drug

AbstractCeftolozane-tazobactam pharmacokinetics during extracorporeal membrane oxygenation (ECMO) has not been previously studied. In this work we report on the ceftolozane and tazobactam plasmatic levels in a lung transplant recipient during ECMO, treated with ceftolozane-tazobactam (2g/1g, intravenously every 8 h, 1 h infusion) for a Pseudomonas aeruginosa pulmonary infection. Ceftolozane Cmax and Cmin, monitored during 96 hrs, remained above 60 and 20 μg/mL, respectively, with optimal drug exposure (100% %TMIC). Tazobactam levels were above 1.9 μg/mL.

Sign in / Sign up

Export Citation Format

Share Document